Trials / Unknown
UnknownNCT03002532
Hippocampal-sparing Whole Brain Radiotherapy for Brain Metastases From Breast Cancer
Whole Brain Irradiation With Hippocampal Sparing for Brain Metastases From Breast Cancer: Neurocognitive Function and Prognosis Analysis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Affiliated Hospital to Academy of Military Medical Sciences · Academic / Other
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Based on evidence that radiation-induced damage to the hippocampus plays a considerable role in neurocognitive decline after cranial irradiation, hippocampal-sparing whole brain radiation therapy (HS-WBRT) has been proposed. This study will investigate the neurocognitive function and prognosis between HS-WBRT and conventional WBRT for the treatment of brain metastases from breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | whole brain radiotherapy |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2017-08-01
- Completion
- 2017-08-01
- First posted
- 2016-12-23
- Last updated
- 2016-12-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03002532. Inclusion in this directory is not an endorsement.